Bellerophon Therapeutics Inc

NASDAQ:BLPH  
2.66
-0.18 (-6.34%)
Earnings Announcements

Bellerophon Provides Clinical Program Update And Reports Third Quarter 2021 Financial Results

Published: 11/15/2021 14:55 GMT
Bellerophon Therapeutics Inc (BLPH) - Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial Results.
Bellerophon Therapeutics Inc - Qtrly Loss per Share $0.49.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.56

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.63

More details on our Analysts Page.